Article Sidebar
Published:
Nov 27, 2025Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
In silico assessment of cinnamon compounds in ulcerative colitis therapy
Abstract
Purpose: To identify potential quality markers (Q-markers) of cinnamon for treating ulcerative colitis (UC) using network pharmacology methodologies and evaluate potential therapeutic markers.
Methods: The GeneCards, Online Mendelian Inheritance in Man (OMIM), and Therapeutic Target Databases (TTD) were employed to identify potential targets and pathways associated with the active components of cinnamon. A multi-component-target interaction network was developed using Cytoscape, and core compounds were evaluated through topological analysis. Molecular docking and visualization analyses of core compounds and key targets were conducted using AutoDock Tools and PyMol to identify potentially therapeutically active components.
Results: A total of 18 active components of cinnamon and 74 UC-related targets were identified. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the mechanisms predominantly involve the PI3K-Akt, HIF-1, and JAK-STAT signaling pathways. Molecular docking demonstrated that cinnamates, ellagic acid, and epigallocatechin gallate significantly bind to core targets (e.g., AKT1, STAT3), indicating their potential as Q-markers in treating UC.
Conclusion: This study comprehensively clarifies the mechanisms through which cinnamon acts on UC, involving the PI3K-Akt, HIF-1, and JAK-STAT signaling pathways. These mechanisms provide a scientific foundation for optimizing the quality standards of cinnamon and its formulations.
